ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,637, issued on Aug. 12, was assigned to Janssen Biotech Inc. (Horsham, Pa.).
"Therapeutic agents and uses thereof" was invented by Sven-Erik Strand (Lund, Sweden), Amanda Thuy Tran (Stockholm) and Sven-Niklas Anders Axelsson (Bjarred, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present application provides an agent comprising or consisting of a binding moiety with specificity for a kallikrein protein (for example, PSA or hK2) for use in the treatment of prostate cancer, and a method for the treatment of prostate cancer in a patient, the method comprising the step of administering a therapeutically effective amount of an agent comprisin...